Cardinal Health Stock Forecast for 2022 - 2025 - 2030

Updated on 12/02/2022

Stock Rating
13
Price Target
$79.00
Consensus
Neutral
Downside
-0.33%
Analysts
5
Stock Rating
13
Downside
-0.33%
Analysts
5
Price Target
$79.00

Cardinal Health Stock Forecast and Price Target

The average price target for Cardinal Health's stock set by five recognized analysts recently is $79.00, which would result in a potential downside of approximately -0.33% if it reached this mark. The estimation is based on a high estimate of $90.00 and a low estimate of $67.00. If you are interested in CAH stock, it is important to also consider its competitors.

$79.00

-0.33% Downside

Hold
Hold

Cardinal Health Fair Value Forecast for 2022 - 2025 - 2030

Cardinal Health's Price has seen impressive growth In the last four years, rising from $49.90 to $50.50 – a growth of 1.20%. In the next year, analysts believe that Fair Value will reach $58.48 – an increase of 15.81%. For the next eight years, the forecast is for Fair Value to grow by 49.91%.

2023 Fair Value Forecast
$58.48
2024 Fair Value Forecast
$64.17
2025 Fair Value Forecast
$65.27
2026 Fair Value Forecast
$77.44
2027 Fair Value Forecast
$86.73
2028 Fair Value Forecast
$78.60
2029 Fair Value Forecast
$74.39
2030 Fair Value Forecast
$75.70
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MSFT Stock Forecast Microsoft Buy 18
$254.69 Buy/Sell $296.98 13.86%
UNH Stock Forecast UnitedHealth Group Outperform 16
$536.91 Buy/Sell $579.33 10.91%
ORCL Stock Forecast Oracle Hold 14
$84.11 Buy/Sell $85.62 -1.91%
ABT Stock Forecast Abbott Laboratories Outperform 14
$107.93 Buy/Sell $128.88 5.62%
IBM Stock Forecast International Business Machine... Outperform 14
$149.16 Buy/Sell $144.43 -6.14%

Cardinal Health Revenue Forecast for 2022 - 2025 - 2030

Cardinal Health's Revenue has seen impressive growth In the last four years, rising from $136.81B to $181.36B – a growth of 32.57%. In the next year, analysts believe that Revenue will reach $185.48B – an increase of 2.27%. For the next eight years, the forecast is for Revenue to grow by 19.52%.

2023 Rev Forecast
$185.48B
2024 Rev Forecast
$194.13B
2025 Rev Forecast
$203.74B
2026 Rev Forecast
$210.55B
2027 Rev Forecast
$219.17B
2028 Rev Forecast
$228.14B
2029 Rev Forecast
$219.71B
2030 Rev Forecast
$216.76B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SAP Stock Forecast SAP Outperform 18
106.32€ Buy/Sell 123.90€ 8.16%
MDT Stock Forecast Medtronic Outperform 13
$79.25 Buy/Sell $91.23 9.15%
CI Stock Forecast Cigna Outperform 14
$323.45 Buy/Sell $295.91 10.37%

Cardinal Health Dividend per Share Forecast for 2022 - 2025 - 2030

In the last four years, Cardinal Health's Dividend per Share has grown by 5.91%, rising from $1.86 to $1.97. For the next year, analysts predict that Dividend per Share will reach $2.07 – an increase of 5.08%. Over the next eight years, experts believe that Cardinal Health's Dividend per Share will grow at a rate of 9.40%.

2023 DPS Forecast
$2.07
2024 DPS Forecast
$2.22
2025 DPS Forecast
$2.44
2026 DPS Forecast
$2.05
2027 DPS Forecast
$2.07
2028 DPS Forecast
$2.09
2029 DPS Forecast
$2.21
2030 DPS Forecast
$2.16
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SYK Stock Forecast Stryker Outperform 15
$240.77 Buy/Sell $236.97 -0.32%
MMM Stock Forecast 3M Hold 16
$125.99 Buy/Sell $147.79 1.20%
HUM Stock Forecast Humana Outperform 15
$548.37 Buy/Sell $504.43 13.06%

Cardinal Health Free Cash Flow Forecast for 2022 - 2025 - 2030

In the last four years, Cardinal Health's Free Cash Flow has seen an increase, rising from $2.38B to $2.74B. This represents a growth of 14.72%. In the next year, 6 analysts estimate that Cardinal Health's Free Cash Flow will decrease by 29.71%, reaching $1.92B. According to professional forecasts, in 2030, Cardinal Health's Free Cash Flow will decrease by 35.67%, reaching $1.76B.

2023 FCF Forecast
$1.92B
2024 FCF Forecast
$1.90B
2025 FCF Forecast
$1.39B
2026 FCF Forecast
$1.40B
2027 FCF Forecast
$2.14B
2028 FCF Forecast
$2.15B
2029 FCF Forecast
$1.90B
2030 FCF Forecast
$1.76B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BSX Stock Forecast Boston Scientific Outperform 15
$46.12 Buy/Sell $49.85 5.16%
ETN Stock Forecast Eaton Outperform 16
$163.36 Buy/Sell $162.20 4.68%
MCK Stock Forecast McKesson Outperform 16
$379.72 Buy/Sell $377.15 11.92%

Cardinal Health Net Income Forecast for 2022 - 2025 - 2030

In the last four years, Cardinal Health's Net Income has seen a drop from $256.00M to $-933.00M – a 464.45% decrease. According to 8 major analysts, Cardinal Health's Net Income will fall by 268.45% in the next year, reaching $1.57B. Professionals believe that By 2030, Cardinal Health's Net Income will fall to $1.77B– a 290.10% decrease from its current value.

2023 NI Forecast
$1.57B
2024 NI Forecast
$1.66B
2025 NI Forecast
$1.52B
2026 NI Forecast
$1.79B
2027 NI Forecast
$1.98B
2028 NI Forecast
$1.88B
2029 NI Forecast
$1.76B
2030 NI Forecast
$1.77B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CNC Stock Forecast Centene Outperform 12
$85.81 Buy/Sell $95.95 16.54%
KMB Stock Forecast Kimberly-Clark Hold 16
$136.60 Buy/Sell $131.81 -6.66%
ECL Stock Forecast Ecolab Outperform 18
$151.94 Buy/Sell $179.10 4.98%

Cardinal Health EBITDA Forecast for 2022 - 2025 - 2030

In the last four years, Cardinal Health's EBITDA has fallen from $3.02B to $2.36B – a 21.91% decrease. In the next year, analysts believe that EBITDA will reach $2.63B – an increase of 11.76%. For the next eight years, the forecast is forEBITDA to grow by 12.72%.

2023 EBITDA Forecast
$2.63B
2024 EBITDA Forecast
$2.77B
2025 EBITDA Forecast
$2.76B
2026 EBITDA Forecast
$2.59B
2027 EBITDA Forecast
$2.59B
2028 EBITDA Forecast
$2.65B
2029 EBITDA Forecast
$2.69B
2030 EBITDA Forecast
$2.66B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LONN Stock Forecast Lonza Group Ltd Outperform 16
CHF509.00 Buy/Sell CHF756.46 54.72%
PH Stock Forecast Parker-Hannifin Outperform 16
$297.52 Buy/Sell $338.22 10.08%
WBA Stock Forecast Walgreens Boots Alliance Hold 11
$41.31 Buy/Sell $40.85 -3.17%

Cardinal Health EBIT Forecast for 2022 - 2025 - 2030

In the last four years, Cardinal Health's EBIT has decreased from $1.99B to $1.66B – a 16.17% drop. In the coming year, analysts are expecting an increase in EBIT, predicting it will reach $2.26B – an increase of 35.77%. Over the next eight years, experts anticipate that EBIT growth for Cardinal Health will be 60.45%.

2023 EBIT Forecast
$2.26B
2024 EBIT Forecast
$2.37B
2025 EBIT Forecast
$2.54B
2026 EBIT Forecast
$2.63B
2027 EBIT Forecast
$2.73B
2028 EBIT Forecast
$2.76B
2029 EBIT Forecast
$2.69B
2030 EBIT Forecast
$2.67B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABC Stock Forecast AmerisourceBergen Outperform 16
$171.63 Buy/Sell $175.00 2.55%
7733 Stock Forecast Olympus Outperform 18
¥2.79k Buy/Sell ¥0.00 13.72%
4543 Stock Forecast Terumo Outperform 18
¥4.09k Buy/Sell ¥0.00 22.28%

Cardinal Health EPS Price Prediction Forecast for 2022 - 2025 - 2030

Cardinal Health's EPS has seen impressive growth In the last four years, rising from $5.00 to $5.06 – a growth of 1.20%. In the next year, analysts believe that EPS will reach $5.86 – an increase of 15.81%. For the next eight years, the forecast is for EPS to grow by 49.91%.

2023 EPS Forecast
$5.86
2024 EPS Forecast
$6.43
2025 EPS Forecast
$6.54
2026 EPS Forecast
$7.76
2027 EPS Forecast
$8.69
2028 EPS Forecast
$7.88
2029 EPS Forecast
$7.45
2030 EPS Forecast
$7.59
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600660 Stock Forecast Fuyao Glass Industry Group Outperform 18
¥37.45 Buy/Sell ¥54.00 28.17%
VIFN Stock Forecast Vifor Pharma Outperform 14
CHF169.05 Buy/Sell CHF142.44 -2.10%
SN. Stock Forecast Smith & Nephew Outperform 18
£10.79 Buy/Sell £22.79 42.82%